Biotech

  • elan

    Athena Neurosciences

    Pharmaceuticals for neurological diseases

    Acquired by Elan Corp., plc
    (ELN)

  • avidialogo05

    Avidia

    New protein structural motifs for treating human disease.

    Acquired by Amgen (AMGN)

  • Calithera Logo New

    Calithera Biosciences

    A new class of anti-cancer therapeutics based on activation of caspases

  • Catalystbio

    Catalyst Biosciences

    Developer of engineered proteases as protein therapeutics that attack targets which cause disease.

    PRIVATE

  • Elcelyx Logo

    Elcelyx Therapeutics

    Elcelyx is a biotechnology company that is creating new therapeutics for the treatment of diabetes and obesity

  • FoldRX Logo

    FoldRx Pharmaceuticals

    Treatments for diseases caused by misfolding of specific proteins

    Acquired by Pfizer

  • GalleonJPEGlogo

    Galleon Pharmaceuticals

    Innovative medicines for pulmonology, neurology, cardiology, sleep medicine and pediatrics

    PRIVATE

  • Globeimmune

    GlobeImmune

    Therapeutic vaccine platform technology targeting infectious disease and cancer

    PRIVATE

  • Morphotek

    Morphotek, Inc.

    Next generation antibodies production technology.

    Acquired by EISIA

  • Mosaic Bio Logo

    Mosaic Biosciences

    Platform for tissue engineering using synthetic smart polymers

  • NaZuraLogo404

    NaZura

    NaZura BioHealth Inc. is focused on developing consumer and pharmaceutical products based on its proprietary Gut Sensory Modulation (GSM) technology.

  • OncoMed Logo

    OncoMed Pharmaceuticals Inc.

    Biological therapeutics targeting cancer stem cells

    PRIVATE

  • orexigen

    Orexigen

    Developer of drug treatments for obesity and related disorders.

    (OREX)

  • Principia Logo

    Principia

    Drug discovery company based on a proprietary chemistry platform that generates novel compounds with enhanced selectivity, high potency and longer duration of effect

  • PromediorOct2012

    Promedior Pharmaceuticals

    Therapeutics to treat fibrosis

    PRIVATE

  • Ra-Pharma-Logo-11-2011

    Ra Pharmaceuticals

    Platform for orally available and cell permeable biologics

  • Replidyne

    Replidyne

    Drug discovery and development focused on a new class of antibiotics

    (RDYN)

  • rpi

    Ribozyme Pharmaceuticals

    RNA-based pharmaceuticals for human disease

    (RZYM)

  • Scioderm Large

    Scioderm

    Scioderm is focused on the development of innovative drugs for the treatment of chronic diseases of the skin.

  • sequana

    Sequana Therapeutics

    Gene discovery via functional genomics

    Acquired by Axys Pharmaceutical (AXPH)

  • Stemgent Logo

    Stemgent

    Reagents for stem cell researchers

    PRIVATE

  • thresholdpharma

    Threshold Pharmaceutical, Inc.

    Developing targeted therapies for treatment of cancer.

    (THLD)

  • TRAGARALogo

    Tragara Pharmaceuticals

    Developer of drugs for the treatment of cancer and inflammation-related diseases.

    PRIVATE

  • Trellis07

    Trellis Bioscience

    Platform technology for monoclonal antibody development and production

    PRIVATE

  • Vapotherm

    Vapotherm

    Vapotherm is developing high flow therapy for clinically effective respiratory support.

  • vical

    Vical

    DNA-based pharmaceuticals for human disease

    (VICL)

All portfolio companies in active funds